Family |
Oleaceae |
Tribe |
Oleeae |
Scientific name |
Ligustrum japonicum Thunberg |
Synonyms |
Ligustridium japonicum (Thunberg) Spach; Ligustrum coriaceum Carrière;
Ligustrum japonicum Thunberg forma pubescens (Koidzumi) Murata; Ligustrum
japonicum Thunberg var. pubescens Koidzumi; Ligustrum japonicum Thunberg
var. rotundifolium Blume; Ligustrum kellerianum Visiani; Ligustrum rotundifolium
(Blume) Hatusima; Ligustrum taquetii H. Léveillé; Ligustrum texanum hort. |
Common name |
(Japanese common name) nezumi-mochi (ネズミモチ, 鼠黐 [meaning: mouse mochi-no-ki
(mochi-no-ki = Ilex integra)]) |
(English common name) Japanese privet, Japanese wax-leaf privet |
Distribution |
(Japan) Honshu (west of Kanto region), Shikoku, Kyushu, Okinawa |
(Other nations) Korea, China, Taiwan |
Chromosomal number |
2n=44 |
Description |
Plants 6-8m tall. Leaves 4-10cm long. Flowers white corollas 5mm, flowering
in May to June. Evergreen. Subarbor trees. |
Reference |
Ligustrum japonicum Thunb. |
Ligustrum japonicum Thunb. |
Mannitol oxidoreductase isolated from vascular plants (US Patent 5268288/1993) |
Inclusion complexes of cyclodextrin and their use in slow release formulations for attracting insects (US Patent 5650160/1997) |
Use of plant extracts for treatment of HIV, HCV and HBV infections (US Patent 5837257/1997) |
Compositions of matter useful in the treatment of viral infections derived from plant extracts (US Patent 5989556/1999) |
Process for preparing an anti-viral medicinal product from plant extracts (US Patent 6214350/2001) |
Turmeric-containing cooking oils and fats (US Patent 6497908/2002) |
Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2 (US Patent 6629835/2003) |
Pharmaceutical composition for the treatment of diabetes mellitus (US Patent 6692777/2004) |
Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 (US Patent 6979470/2005) |
Compositions that treat or inhibit pathological conditions associated with inflammatory response (US Patent 7270835/2007) |